Cargando…

Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study

Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryant, Tyler S., Duggal, Priya, Yu, Bing, Morrison, Alanna C., Shafi, Tariq, Ehret, Georg, Franceschini, Nora, Boerwinkle, Eric, Coresh, Josef, Tin, Adrienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397986/ https://www.ncbi.nlm.nih.gov/pubmed/30906589 http://dx.doi.org/10.1155/2019/2137629

Ejemplares similares

Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study
por: Loomis, Stephanie J., et al.
Publicado: (2019)

Genetic Determinants Influencing Human Serum Metabolome among African Americans
por: Yu, Bing, et al.
Publicado: (2014)

Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study
por: Loomis, Stephanie J., et al.
Publicado: (2018)

Interaction between the NOS3 Gene and Obesity as a Determinant of Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
por: Bressler, Jan, et al.
Publicado: (2013)

Revisiting the optical properties of the FMO protein
por: Milder, Maaike T. W., et al.
Publicado: (2010)

MicroRNAs in the miR-17 and miR-15 families are downregulated in chronic kidney disease with hypertension
por: Nandakumar, Priyanka, et al.
Publicado: (2017)

Discovery of the Odderon by TOTEM experiments and the FMO approach
por: Martynov, Evgenij, et al.
Publicado: (2019)

Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities Study
por: Bernard, Lauren, et al.
Publicado: (2022)

Contributions of rare coding variants in hypotension syndrome genes to population blood pressure variation
por: Nandakumar, Priyanka, et al.
Publicado: (2018)

Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension
por: Zhou, Linda, et al.
Publicado: (2022)

Fluorescence-excitation and Emission Spectroscopy on Single FMO Complexes
por: Löhner, Alexander, et al.
Publicado: (2016)

Using Multiple Measures for Quantitative Trait Association Analyses: Application to Estimated Glomerular Filtration Rate (eGFR)
por: Tin, A, et al.
Publicado: (2013)

Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study
por: Tin, Adrienne, et al.
Publicado: (2015)

Production of drug metabolites by human FMO3 in Escherichia coli
por: Catucci, Gianluca, et al.
Publicado: (2020)

FMO4 shapes immuno‐metabolic reconfiguration in hepatocellular carcinoma
por: Luo, Yan, et al.
Publicado: (2022)

Direct Estimates of the Genomic Contributions to Blood Pressure Heritability within a Population-Based Cohort (ARIC)
por: Salfati, Elias, et al.
Publicado: (2015)

Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease
por: Tin, Adrienne, et al.
Publicado: (2014)

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease
por: Han, Zhongji, et al.
Publicado: (2018)

Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease
por: Sekula, Peggy, et al.
Publicado: (2020)

Socioeconomic Status and Incidence of Hospitalization With Lower‐Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study
por: Vart, Priya, et al.
Publicado: (2017)

An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1
por: Mekonnen, Ephrem, et al.
Publicado: (2017)

Sequence Analysis of Six Blood Pressure Candidate Regions in 4,178 Individuals: The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study
por: Morrison, Alanna C., et al.
Publicado: (2014)

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients
por: Robinson-Cohen, Cassianne, et al.
Publicado: (2016)

Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study
por: Bressler, Jan, et al.
Publicado: (2015)

Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study
por: Vu, Khanh N., et al.
Publicado: (2016)

Hybrid QM/MM study of FMO complex with polarized protein-specific charge
por: Jia, Xiangyu, et al.
Publicado: (2015)

Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine
por: Gao, Chongliang, et al.
Publicado: (2017)

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
por: El-Serafi, Ibrahim, et al.
Publicado: (2017)

Drug metabolite synthesis by immobilized human FMO3 and whole cell catalysts
por: Gao, Chongliang, et al.
Publicado: (2019)

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers
por: Tang, Yong-Jun, et al.
Publicado: (2017)

Investigating the biochemical signatures and physiological roles of the FMO family using molecular phylogeny
por: Nicoll, C.R., et al.
Publicado: (2023)

Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer
por: Wu, Lichun, et al.
Publicado: (2023)

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
por: Gong, Xumeng, et al.
Publicado: (2023)

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
por: Seidelmann, Sara B., et al.
Publicado: (2018)

Association of Estimated Glomerular Filtration Rate and Urinary Uromodulin Concentrations with Rare Variants Identified by UMOD Gene Region Sequencing
por: Köttgen, Anna, et al.
Publicado: (2012)

Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis
por: Geier, Martina, et al.
Publicado: (2015)

Correction: Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
Publicado: (2017)

Nicotine Dependence is Associated with Functional Variation in FMO3, an Enzyme that Metabolizes Nicotine in the Brain
por: Teitelbaum, Aaron M., et al.
Publicado: (2017)

Exciton Lifetime Distributions and Population Dynamics in the FMO Protein Complex from Prosthecochloris aestuarii
por: Reinot, Tonu, et al.
Publicado: (2021)

Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans
por: Park, Jin-Woo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ktjhi7s8r07n42b0b86up24bcf